The global coronavirus pandemic has had a marked effect on the entire industry since early 2020, it has caused delays in investment decisions and forced many organisations to reassess their production requirements and with borders being closed, or occasionally and unpredictably difficult to cross, it has highlighted the need to mitigate supply chain disruption.
Dohmeyer was approached by, and has become the chosen partner of, many pharmaceutical companies for its experience and expertise in designing equipment for new and modified applications. The unprecedented global impact of Covid-19 has accelerated work on the controlled rate freezing, transport and storage of vaccines. The company has been at the vanguard of this research and development, and with its own highly skilled engineering team it has been able to produce new designs and concepts – sometimes based on existing machinery, but in other cases brand new machinery designed from a blank sheet of paper to fulfil a requirement.
‘Supercooling’ samples and vaccines
